Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 1300 of 1475 entries
View as:

Evaluation of Safety and Effectiveness on Oral Anticoagulants

Phase: N/A Priority: Normal
NCT ID: NCT03765242 Org: User:
Start: 09/21/18 End: 12/25/20 Due: 12/25/21

An Investigational Immuno-therapy Study Of Nivolumab In Combination With Trametinib With Or Without Ipilimumab In Participants With Previously Treated Cancer of the Colon or Rectum That Has Spread

Phase: N/A Priority: Normal
NCT ID: NCT03377361 Org: User:
Start: 01/31/18 End: 11/04/24 Due: 11/04/25

Study to Determine the Safety and Effectiveness of Antiviral Combination Therapy to Treat Hepatitis C Virus (HCV) in Patients Who Have Previously Not Received the Standard of Care

Phase: N/A Priority: Normal
NCT ID: NCT01359644 Org: User:
Start: 06/30/11 End: 10/31/13 Due: 10/31/14

Prospective Research Assessment in Multiple Myeloma: An Observational Evaluation (PREAMBLE)

Phase: N/A Priority: Normal
NCT ID: NCT01838512 Org: User:
Start: 06/13/12 End: 03/31/30 Due: 03/31/31

Phase III China GT 1b Interferon (IFN) Intolerant Prev Exclude Dual

Phase: N/A Priority: Normal
NCT ID: NCT01995266 Org: User:
Start: 02/28/14 End: 07/31/15 Due: 07/31/16

Drug-Drug Interaction (DDI) w/Ketoconazole or Fluconazole

Phase: N/A Priority: Normal
NCT ID: NCT00860275 Org: User:
Start: 04/30/09 End: 06/30/09 Due: 06/30/10

A Nationwide Registry Study of Patients With Nonvalvular Atrial Fibrillation Initiating Oral Anticoagulation Therapies In The Early Period Following Apixaban Marketing In Denmark

Phase: N/A Priority: Normal
NCT ID: NCT02591732 Org: User:
Start: 08/31/14 End: 06/30/15 Due: 06/30/16

Safety and Efficacy of Abatacept Versus Placebo in Participants With Psoriatic Arthritis

Phase: N/A Priority: Normal
NCT ID: NCT00534313 Org: User:
Start: 11/30/07 End: 05/31/11 Due: 05/31/12

A Study to Assess Deucravacitinib Safety in Pregnancy

Phase: N/A Priority: Normal
NCT ID: NCT07017699 Org: User:
Start: 03/21/25 End: 02/28/29 Due: 02/28/30

A Phase I Study to Determine Absorption, Distribution, Metabolism, and Elimination of a Single Radiolabeled Dose of Brivanib (BMS-582664)

Phase: N/A Priority: Normal
NCT ID: NCT00435669 Org: User:
Start: 09/30/07 End: 06/30/08 Due: 06/30/09

Study to Determine the Effectiveness of Antiviral Combination Therapy to Treat Hepatitis C Virus (HCV) Infected Patients Who Have Previously Failed Standard of Care

Phase: N/A Priority: Normal
NCT ID: NCT01012895 Org: User:
Start: 12/31/09 End: 02/28/14 Due: 02/28/15

A Study to Assess the Effect of Famotidine on the Drug Levels of Afimetoran in Healthy Participants

Phase: N/A Priority: Normal
NCT ID: NCT05866627 Org: User:
Start: 07/04/23 End: 03/01/26 Due: 03/01/27

Safety and Efficacy Study of Daclatasvir (BMS-790052) Plus Pegylated Interferon-Alfa 2a and Ribavirin in Patients Coinfected With Untreated Hepatitis C Virus and HIV Virus

Phase: N/A Priority: Normal
NCT ID: NCT01471574 Org: User:
Start: 12/31/11 End: 09/30/14 Due: 09/30/15

A Study of the Safety and Pharmacokinetics of Single Ascending Oral Doses of INX-08189 in Healthy Subjects

Phase: N/A Priority: Normal
NCT ID: NCT01159808 Org: User:
Start: 05/31/10 End: 10/31/10 Due: 10/31/11

A Study to Assess BMS-986460 in Participants With Metastatic Castration-resistant Prostate Cancer

Phase: N/A Priority: Normal
NCT ID: NCT06067841 Org: User:
Start: 10/18/23 End: 01/16/29 Due: 01/16/30

The Study of How Long Participants Stay in the Hospital After Receiving Apixaban for a Blood Clot in the Lung

Phase: N/A Priority: Normal
NCT ID: NCT03595891 Org: User:
Start: 01/20/17 End: 01/29/21 Due: 01/29/22

Study of Dasatinib (BMS-354825) in Patients With Advanced Estrogen/Progesterone Receptor-positive (ER+/PR+) or Her2/Neu-positive (Her2/Neu+)Breast Cancer

Phase: N/A Priority: Normal
NCT ID: NCT00371345 Org: User:
Start: 12/31/06 End: 05/31/09 Due: 05/31/10

A Study of Adjunctive Aripiprazole in Patients With Major Depressive Disorder

Phase: N/A Priority: Normal
NCT ID: NCT00095758 Org: User:
Start: 09/30/04 End: 12/31/06 Due: 12/31/07

Study of Dasatinib and Docetaxel in Metastatic Hormone Refractory Prostate Cancer

Phase: N/A Priority: Normal
NCT ID: NCT00439270 Org: User:
Start: 07/31/07 End: 01/31/13 Due: 01/31/14

A Study to Evaluate CC-486/Onureg in Participants With Moderate or Severe Hepatic Impairment Compared With Normal Hepatic Function in Participants With Myeloid Malignancies

Phase: N/A Priority: Normal
NCT ID: NCT05209295 Org: User:
Start: 07/12/24 End: 06/30/25 Due: 06/30/26

A Study of Nivolumab and Ipilimumab Combined With Chemotherapy Compared to Chemotherapy Alone in First Line NSCLC

Phase: N/A Priority: Normal
NCT ID: NCT03215706 Org: User:
Start: 08/24/17 End: 10/18/24 Due: 10/18/25

A Study to Evaluate Effectiveness and Safety of Deucravacitinib (BMS-986165) Compared With Placebo in Participants With Active Systemic Lupus Erythematosus

Phase: N/A Priority: Normal
NCT ID: NCT05620407 Org: User:
Start: 01/12/23 End: 12/17/27 Due: 12/17/28

A Study of Nivolumab Intravenous (IV) to Subcutaneous (SC) Switch in Adjuvant Melanoma and Bladder Cancer

Phase: N/A Priority: Normal
NCT ID: NCT05496192 Org: User:
Start: 05/31/23 End: 06/24/26 Due: 06/24/27

A Study Assessing the Health-Related Quality of Life (HRQoL) in Participants With Relapsed and/or Refractory Multiple Myeloma (RRMM) With Triple Class Exposure

Phase: N/A Priority: Normal
NCT ID: NCT05217082 Org: User:
Start: 02/22/22 End: 08/03/22 Due: 08/03/23

A Study Comparing the Effects of Famotidine Pretreatment and of Food on the Relative Bioavailability of BMS-986165 in Healthy Volunteers

Phase: N/A Priority: Normal
NCT ID: NCT04209699 Org: User:
Start: 12/27/19 End: 02/11/20 Due: 02/11/21